Floatz logo

UMBELLATINE

Colorectal Adenomas

Jing-yuan Fang, MD, Ph. DSmall moleculePhase 2/3Active
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Colorectal Adenomas cohort.

Asset / SponsorPhaseRating
Mesalamine
UMC Utrecht
Phase 2B
Dfn-15
University of Alabama at Birmingham
Phase 2B
Linaclotide
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase 2CCC
Acetylsalicylic Acid
University of Edinburgh
Phase 2CCC
muc1 peptide-poly-iclc vaccine
National Cancer Institute (NCI)
Phase 2CCC

View all 11 →

Same molecule, other indications

UMBELLATINE is also rated in:

inherited lipid metabolism disorderDormant
BBB
Indicative ·
72 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
BB
Indicative ·
69 / 100
View asset →
metabolic dysfunction-associated steatotic liver diseaseDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →